1-Bromopropane

1-Bromopropane (n-propyl bromide, nPB) emerged as a commercial solvent in the 1990s when industry sought alternatives to methyl chloroform and CFCs following the Montreal Protocol on ozone-depleting substances. [1] Chemical manufacturers promoted it as a drop-in replacement for vapor degreasing, aerosol solvent, and dry-cleaning applications, emphasizing its low ozone depletion potential. By the early 2000s it was used extensively in electronics cleaning, foam cushion manufacturing (spray adhesives in furniture factories), and garment dry cleaning. However, within a few years, clusters of severe neurological illness began appearing among workers using 1-BP — particularly spray adhesive applicators in furniture plants. Workers developed gait abnormalities, numbness and tingling in extremities, and in severe cases paraplegia and cognitive impairment. [2] NIOSH investigations in 2001–2003 documented these outbreaks and linked them to 1-BP exposure. The compound turned out to be a potent neurotoxicant via mechanisms similar to hexane and methyl butyl ketone, disrupting axonal transport in peripheral and central nervous system neurons. The NTP subsequently found evidence of carcinogenicity in rodents, and the EPA classified it as a probable human carcinogen in 2013. [3] Despite this history, 1-BP remained commercially available and widely used for years, and OSHA did not establish a permissible exposure limit until the EPA's 2020 risk evaluation under TSCA began imposing restrictions.

Inhalation of 1-BP vapors during occupational use is the primary route — it is highly volatile and vapor concentrations build rapidly in enclosed spaces. Spray adhesive workers, dry cleaning employees, and electronics degreasing workers face the highest exposures. Dermal absorption is significant as the liquid penetrates skin readily. Consumer exposure can occur from aerosol products containing 1-BP, including some spray adhesives and cleaning sprays.

1-BP causes toxic neuropathy through metabolic generation of reactive intermediates (including bromoacetone and 3-bromopropionic acid) that alkylate neural proteins and disrupt axonal cytoskeletal integrity. [2] Effects range from peripheral neuropathy (numbness, weakness) to central nervous system damage (spastic paraplegia, ataxia) depending on exposure level and duration. The neurological damage can be permanent at high exposures. The EPA's TSCA risk evaluation found unreasonable risk to workers and the general public, leading to proposed prohibitions on several uses. It is classified as a probable human carcinogen based on animal evidence of lung and skin tumors.

Workers in furniture manufacturing (spray adhesive use), dry cleaning, electronics assembly and degreasing, and aerospace parts cleaning face the highest risk. Hobbyists using 1-BP-containing adhesive or cleaning aerosols in poorly ventilated spaces are also at risk. Workers in confined spaces (spray booths, small workrooms) without adequate ventilation are particularly vulnerable.

1. Switch to alternative solvents — many 1-BP uses can be replaced with aqueous cleaners, d-limonene, or other less toxic options; check the EPA TSCA substitutes list. 2. If 1-BP must be used, ensure continuous local exhaust ventilation and use NIOSH-approved organic vapor respirators, not just dust masks. 3. Wear chemical-resistant gloves (nitrile or neoprene) to prevent skin absorption. 4. Monitor air concentrations with personal sampling to verify they stay below the NIOSH recommended ceiling of 0.1 ppm. 5. Report any tingling, numbness, or gait changes to a physician immediately — early detection can prevent permanent nerve damage.